Agilon Health Inc (AGL) volume exceeds 7.73 million: A new investment opportunity for investors

Agilon Health Inc (NYSE: AGL) on Friday, soared 4.39% from the previous trading day, before settling in for the closing price of $2.96. Within the past 52 weeks, AGL’s price has moved between $1.50 and $7.73.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 53.71%. The company achieved an average annual earnings per share of -15.79%. With a float of $303.29 million, this company’s outstanding shares have now reached $411.96 million.

Let’s determine the extent of company efficiency that accounts for 1117 employees. In terms of profitability, gross margin is -1.22%, operating margin of -6.17%, and the pretax margin is -5.56%.

Agilon Health Inc (AGL) Breakdown of a Key Holders of the stock

Observing investor behavior towards Medical Care Facilities industry stocks is more important than anything else. The insider ownership of Agilon Health Inc is 26.39%, while institutional ownership is 80.60%. The most recent insider transaction that took place on Dec 13 ’24, was worth 55,085. In this transaction Director of this company bought 25,000 shares at a rate of $2.20, taking the stock ownership to the 73,166 shares. Before that another transaction happened on Dec 11 ’24, when Company’s Director bought 25,062 for $2.01, making the entire transaction worth $50,269. This insider now owns 66,144 shares in total.

Agilon Health Inc (AGL) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.04 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -15.79% per share during the next fiscal year.

Agilon Health Inc (NYSE: AGL) Trading Performance Indicators

Agilon Health Inc (AGL) is currently performing well based on its current performance indicators. A quick ratio of 1.29 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.23.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.34 in one year’s time.

Technical Analysis of Agilon Health Inc (AGL)

Looking closely at Agilon Health Inc (NYSE: AGL), its last 5-days average volume was 7.4 million, which is a jump from its year-to-date volume of 5.39 million. As of the previous 9 days, the stock’s Stochastic %D was 81.65%. Additionally, its Average True Range was 0.24.

During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 53.00%, which indicates a significant decrease from 86.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 80.93% in the past 14 days, which was lower than the 118.39% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.14, while its 200-day Moving Average is $4.30. However, in the short run, Agilon Health Inc’s stock first resistance to watch stands at $3.27. Second resistance stands at $3.45. The third major resistance level sits at $3.62. If the price goes on to break the first support level at $2.93, it is likely to go to the next support level at $2.76. Now, if the price goes above the second support level, the third support stands at $2.58.

Agilon Health Inc (NYSE: AGL) Key Stats

Market capitalization of the company is 1.27 billion based on 412,018K outstanding shares. Right now, sales total 4,316 M and income totals -262,600 K. The company made 1,451 M in profit during its latest quarter, and -117,620 K in sales during its previous quarter.